Author Archive: BIOtechNOW Editor

New Type of Prospective Survey Initiative

scientist-eyedropper

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating and life-threatening diseases. To help advance innovation and promote the development of the next generation of treatments and cures, we must acknowledge that the scientific method does not operate in a vacuum. Robust, interactive FDA-Sponsor communication is a key element of modern drug development. However, in order to improve the drug development enterprise and the FDA review process further, the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Delivering the Right Dose, Less Often

medical_research

Biologics are a growing area of drug development, including life-threatening and life-changing disorders such as cancer and rheumatoid arthritis. However, many biologics have short half-lives, and need to be dosed daily. To make them more convenient to use, as well as safer and more effective, researchers are developing delivery systems that keep the biologics in the body for longer, reducing the frequency of dosing. Swedish company Affibody is using the natural affinity of a naturally-occurring Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Acts of Support

hahn

Because small biotechnology companies do not have product revenue, burdensome regulations have an outsized effect on them. One-size-fits-all compliance requirements – such as Section 404(b) of the Sarbanes-Oxley Act (SOX) – divert funds from the lab and slow the development process. We have already seen the benefits that positive legislative reform can have for capital formation for emerging growth companies (EGCs). The JOBS Act has led to a sea change in the regulatory landscape and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

US Public Organizations Leading Genomic Research, with Europe and Asia Catching Up

Gareth Williams  - Head Shot (March 2013) C High(2146527_1)

Since before the mapping of the human genome just over a decade ago, we have been applying our growing understanding the genome and associated –omes to medical and industrial uses. Thanks to this understanding, we now have the ability to pinpoint a specific genetic variation in a specific patient which can predict sensitivity to certain drugs. But where is innovation in genomics coming from? And where is it going? What roles are emerging markets playing? Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Richard Branson’s Biofuel Enthusiasm

BIOORG-Campaign-Keynote115x76

The serial entrepreneur believes in investing in many alternative sources of energy including biofuels. Legendary entrepreneur/business leader Sir Richard Charles Nicholas Branson is known for pushing the envelope with his Virgin Group. More than 400 companies exist under the moniker, the most well-known including the Virgin Records music label, the American airline Virgin America, cell phone provider Virgin Mobile, and Virgin Galactic, the world’s first commercial spaceline. Branson’s initiatives toward environmental sustainability and climate change Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,